Kepp O, Loos F, Liu P, Kroemer G. Extracellular nucleosides and nucleotides as immunomodulators. Immunol Rev. 2017;280:83–92.
Rissiek B, Haag F, Boyer O, Koch-Nolte F, Adriouch S. P2X7 on mouse T cells: one channel, many capabilities. Entrance Immunol. 2015;6:204.
Mishra A, Behura A, Kumar A, Naik L, Swain A, Das M, Sarangi SS, Dokania P, Dirisala VR, Bhutia SK, et al. P2X7 receptor in multifaceted mobile signalling and its relevance as a possible therapeutic goal in numerous illnesses. Eur J Pharmacol. 2021;906: 174235.
Schwarz N, Fliegert R, Adriouch S, Seman M, Guse AH, Haag F, Koch-Nolte F. Activation of the P2X7 ion channel by soluble and covalently sure ligands. Purinergic Sign. 2009;5:139–49.
Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and irritation. Pharmacol Ther. 2006;112:358–404.
Hubert S, Rissiek B, Klages Ok, Huehn J, Sparwasser T, Haag F, Koch-Nolte F, Boyer O, Seman M, Adriouch S. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment by way of the ART2-P2X7 pathway. J Exp Med. 2010;207:2561–8.
Gu B, Bendall LJ, Wiley JS. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the identical receptor however totally different metalloproteases. Blood. 1998;92:946–51.
Scheuplein F, Schwarz N, Adriouch S, Krebs C, Bannas P, Rissiek B, Seman M, Haag F, Koch-Nolte F. NAD+ and ATP launched from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells. J Immunol. 2009;182:2898–908.
Moon H, Na HY, Chong KH, Kim TJ. P2X7 receptor-dependent ATP-induced shedding of CD27 in mouse lymphocytes. Immunol Lett. 2006;102:98–105.
Grassi F. The P2X7 receptor as regulator of T cell growth and performance. Entrance Immunol. 2020;11:1179.
Grassi F, Marino R. The P2X7 receptor in mucosal adaptive immunity. Purinergic Sign. 2023. https://doi.org/10.1007/s11302-023-09939-w.
Pelegrin P. P2X7 receptor and the NLRP3 inflammasome: Companions in crime. Biochem Pharmacol. 2021;187: 114385.
Mitra S, Sarkar A. Microparticulate P2X7 and GSDM-D mediated regulation of purposeful IL-1beta launch. Purinergic Sign. 2019;15:119–23.
Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S. The P2X7 receptor in an infection and irritation. Immunity. 2017;47:15–31.
Liu JP, Liu SC, Hu SQ, Lu JF, Wu CL, Hu DX, Zhang WJ. ATP ion channel P2X purinergic receptors in irritation response. Biomed Pharmacother. 2023;158: 114205.
Cheng N, Zhang L, Liu L. Understanding the position of purinergic P2X7 receptors within the gastrointestinal system: a scientific evaluate. Entrance Pharmacol. 2021;12: 786579.
Liu Y, Liu X. Analysis progress of P2X7 receptor in inflammatory bowel illness. Scand J Gastroenterol. 2019;54:521–7.
Heiss Ok, Janner N, Mahnss B, Schumacher V, Koch-Nolte F, Haag F, Mittrucker HW. Excessive sensitivity of intestinal CD8+ T cells to nucleotides signifies P2X7 as a regulator for intestinal T cell responses. J Immunol. 2008;181:3861–9.
Trautmann A. Extracellular ATP within the immune system: greater than only a “hazard sign.” Sci Sign. 2009;2:pe6.
Cesaro A, Brest P, Hofman V, Hebuterne X, Wildman S, Ferrua B, Marchetti S, Doglio A, Vouret-Craviari V, Galland F, et al. Amplification loop of the inflammatory course of is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am J Physiol Gastrointest Liver Physiol. 2010;299:G32-42.
Jiang ZF, Wu W, Hu HB, Li ZY, Zhong M, Zhang L. P2X7 receptor because the regulator of T-cell operate in intestinal barrier disruption. World J Gastroenterol. 2022;28:5265–79.
Neves AR, Castelo-Branco MT, Figliuolo VR, Bernardazzi C, Buongusto F, Yoshimoto A, Nanini HF, Coutinho CM, Carneiro AJ, Coutinho-Silva R, de Souza HS. Overexpression of ATP-activated P2X7 receptors within the intestinal mucosa is implicated within the pathogenesis of Crohn’s illness. Inflamm Bowel Dis. 2014;20:444–57.
Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, El-Galeel YA, El-Hefnawy A, Shabaka D, Khalifa A, et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by concentrating on P2X7R/NLRP3 and MyD88/NF-kappaB signaling in DSS-induced colitis in rats. Life Sci. 2021;270: 119123.
Hofman P, Cherfils-Vicini J, Bazin M, Ilie M, Juhel T, Hébuterne X, Gilson E, Schmid-Alliana A, Boyer O, Adriouch S, Vouret-Craviari V. Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens irritation however will increase tumor incidence in a mouse mannequin of colitis-associated most cancers. Most cancers Res. 2015;75:835–45.
Bernardazzi C, Castelo-Branco MTL, Pego B, Ribeiro BE, Rosas SLB, Santana PT, Machado JC, Leal C, Thompson F, Coutinho-Silva R, de Souza HSP. The P2X7 receptor promotes colorectal irritation and tumorigenesis by modulating intestine microbiota and the inflammasome. Int J Mol Sci. 2022;23:4616.
Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, et al. Replace of P2X receptor properties and their pharmacology: IUPHAR evaluate 30. Br J Pharmacol. 2021;178:489–514.
Muyldermans S. Nanobodies: pure single-domain antibodies. Annu Rev Biochem. 2013;82:775–97.
Danquah W, Meyer-Schwesinger C, Rissiek B, Pinto C, Serracant-Prat A, Amadi M, Iacenda D, Knop JH, Hammel A, Bergmann P, et al. Nanobodies that block gating of the P2X7 ion channel ameliorate irritation. Sci Transl Med. 2016;8:366ra162.
Koch-Nolte F, Eichhoff A, Pinto-Espinoza C, Schwarz N, Schafer T, Menzel S, Haag F, Demeules M, Gonde H, Adriouch S. Novel biologics concentrating on the P2X7 ion channel. Curr Opin Pharmacol. 2019;47:110–8.
Danquah W, Koch-Nolte F, Stortelers C, Toon L. P2X7 receptor antagonists and agonists, vol. WO2013178783A1. Munich: European Patent Workplace; 2013.
Demeules M, Scarpitta A, Abad C, Gonde H, Hardet R, Pinto-Espinoza C, Eichhoff AM, Schafer W, Haag F, Koch-Nolte F, Adriouch S. Analysis of P2X7 receptor operate in tumor contexts utilizing rAAV vector and nanobodies (AAVnano). Entrance Oncol. 2020;10:1699.
Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G, Deterre P, Haag F, Koch-Nolte F. NAD-induced T cell loss of life: ADP-ribosylation of cell floor proteins by ART2 prompts the cytolytic P2X7 purinoceptor. Immunity. 2003;19:571–82.
Adriouch S, Hubert S, Pechberty S, Koch-Nolte F, Haag F, Seman M. NAD+ launched throughout irritation participates in T cell homeostasis by inducing ART2-mediated loss of life of naive T cells in vivo. J Immunol. 2007;179:186–94.
Pinto-Espinoza Carolina, Guillou C, Rissiek B, Wilmes M, Javidi E, Schwarz N, Junge M, Haag F, Liaukouskaya N, Wanner N, Nicke A, Stortelers C, Tan Y-T, Adriouch S, Magnus T, Koch-Nolte F. Efficient concentrating on of microglial P2X7 following intracerebroventricular supply of nanobodies and nanobody-encoding AAVs. Entrance Pharmacol. 2022;13. https://doi.org/10.3389/fphar.2022.1029236.
Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine mannequin: an indispensable device for advancing our understanding of inflammatory bowel illnesses pathogenesis. World J Gastroenterol. 2017;23:6016–29.
Colella P, Ronzitti G, Mingozzi F. Rising points in AAV-mediated in vivo gene remedy. Mol Ther Strategies Clin Dev. 2018;8:87–104.
Pupo A, Fernandez A, Low SH, Francois A, Suarez-Amaran L, Samulski RJ. AAV vectors: the Rubik’s dice of human gene remedy. Mol Ther. 2022;30:3515–41.
Srivastava A. Rationale and techniques for the event of secure and efficient optimized AAV vectors for human gene remedy. Mol Ther Nucleic Acids. 2023;32:949–59.
Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene remedy supply. Nat Rev Drug Discov. 2019;18:358–78.
Fu Q, Polanco A, Lee YS, Yoon S. Essential challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing. Biotechnol Bioeng. 2023. https://doi.org/10.1002/bit.28412.
Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene remedy. Nat Rev Genet. 2020;21:255–72.
Shen W, Liu S, Ou L. rAAV immunogenicity, toxicity, and sturdiness in 255 scientific trials: A meta-analysis. Entrance Immunol. 2022;13:1001263.
Grossen P, Skaripa Koukelli I, van Haasteren J, Machado AHE, Duerr C. The ice age: a evaluate on formulation of adeno-associated virus therapeutics. Eur J Pharm Biopharm. 2023. https://doi.org/10.1016/j.ejpb.2023.07.002.
Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. Broad safety towards influenza an infection by vectored immunoprophylaxis in mice. Nat Biotechnol. 2013;31:647–52.
Brady JM, Baltimore D, Balazs AB. Antibody gene switch with adeno-associated viral vectors as a way for HIV prevention. Immunol Rev. 2017;275:324–33.
Metzger MW, Walser SM, Aprile-Garcia F, Dedic N, Chen A, Holsboer F, Arzt E, Wurst W, Deussing JM. Genetically dissecting P2rx7 expression inside the central nervous system utilizing conditional humanized mice. Purinergic Sign. 2017;13:153–70.
Vultaggio-Poma V, Falzoni S, Salvi G, Giuliani AL, Di Virgilio F. Signalling by extracellular nucleotides in well being and illness. Biochim Biophys Acta Mol Cell Res. 2022;1869: 119237.
Wan P, Liu X, Xiong Y, Ren Y, Chen J, Lu N, Guo Y, Bai A. Extracellular ATP mediates inflammatory responses in colitis by way of P2 x 7 receptor signaling. Sci Rep. 2016;6:19108.
Marques CC, Castelo-Branco MT, Pacheco RG, Buongusto F, Rosario A, Schanaider A, Coutinho-Silva R, de Souza HS. Prophylactic systemic P2X7 receptor blockade prevents experimental colitis. Biochim Biophys Acta. 2014;1842:65–78.
Evangelinellis MM, Souza RF, Mendes CE, Castelucci P. Results of a P2X7 receptor antagonist on myenteric neurons within the distal colon of an experimental rat mannequin of ulcerative colitis. Histochem Cell Biol. 2022;157:65–81.
Jo S, Bean BP. Inhibition of neuronal voltage-gated sodium channels by good blue G. Mol Pharmacol. 2011;80:247–57.
Homerin G, Jawhara S, Dezitter X, Baudelet D, Dufrenoy P, Rigo B, Millet R, Furman C, Rage G, Lipka E, et al. Pyroglutamide-based P2X7 receptor antagonists concentrating on inflammatory bowel illness. J Med Chem. 2020;63:2074–94.
Wetzel A, Scholtka B, Gerecke C, Kleuser B. Epigenetic histone modulation contributes to enhancements in inflammatory bowel illness by way of EBI3. Cell Mol Life Sci. 2020;77:5017–30.
Chen Z, Wang S, Li L, Huang Z, Ma Ok. Anti-inflammatory impact of IL-37-producing T-cell inhabitants in DSS-induced continual inflammatory bowel illness in mice. Int J Mol Sci. 2018;19:3884.
Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, Decker T, Muller M, Strobl B, Schleper C, et al. Intestinal microbiota signatures related to irritation historical past in mice experiencing recurring colitis. Entrance Microbiol. 2015;6:1408.
Jiang Q, Li W, Zhu X, Yu L, Lu Z, Liu Y, Ma B, Cheng L. Estrogen receptor beta alleviates inflammatory lesions in a rat mannequin of inflammatory bowel illness by way of down-regulating P2X7R expression in macrophages. Int J Biochem Cell Biol. 2021;139: 106068.
Gurevich EV, Gurevich VV. Therapeutic potential of small molecules and engineered proteins. Handb Exp Pharmacol. 2014;219:1–12.
Nemetz N, Abad C, Lawson G, Nobuta H, Chhith S, Duong L, Tse G, Braun J, Waschek JA. Induction of colitis and fast growth of colorectal tumors in mice poor within the neuropeptide PACAP. Int J Most cancers. 2008;122(8):1803–9. https://doi.org/10.1002/ijc.23308.
Gonde H, Demeules M, Hardet R, Scarpitta A, Junge M, Pinto-Espinoza C, Varin R, Koch-Nolte F, Boyer O, Adriouch S. A methodological method utilizing rAAV vectors encoding nanobody-based biologics to guage ARTC2.2 and P2X7 in vivo. Entrance Immunol. 2021;12:704408.
Ghetie V, Popov S, Borvak J, Radu C, Matesoi D, Medesan C, Ober RJ, Ward ES. Growing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol. 1997;15:637–40.
Scheuplein F, Rissiek B, Driver JP, Chen YG, Koch-Nolte F, Serreze DV. A recombinant heavy chain antibody method blocks ART2 mediated deletion of an iNKT cell inhabitants that upon activation inhibits autoimmune diabetes. J Autoimmun. 2010;34:145–54.
Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, Hoyer D, Insel PA, Izzo AA, Ji Y, MacEwan DJ, Sobey CG, Stanford SC, Teixeira MM, Wonnacott S, Ahluwalia A. Experimental design and evaluation and their reporting II: up to date and simplified steering for authors and peer reviewers. Br J Pharmacol. 2018;175(7):987–93. https://doi.org/10.1111/bph.14153.
